Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 157

1.

Bipolar mixed features - Results from the comparative effectiveness for bipolar disorder (Bipolar CHOICE) study.

Tohen M, Gold AK, Sylvia LG, Montana RE, McElroy SL, Thase ME, Rabideau DJ, Nierenberg AA, Reilly-Harrington NA, Friedman ES, Shelton RC, Bowden CL, Singh V, Deckersbach T, Ketter TA, Calabrese JR, Bobo WV, McInnis MG.

J Affect Disord. 2017 Apr 5;217:183-189. doi: 10.1016/j.jad.2017.03.070. [Epub ahead of print]

PMID:
28411507
2.

Clinical correlates of acute bipolar depressive episode with psychosis.

Caldieraro MA, Sylvia LG, Dufour S, Walsh S, Janos J, Rabideau DJ, Kamali M, McInnis MG, Bobo WV, Friedman ES, Gao K, Tohen M, Reilly-Harrington NA, Ketter TA, Calabrese JR, McElroy SL, Thase ME, Shelton RC, Bowden CL, Kocsis JH, Deckersbach T, Nierenberg AA.

J Affect Disord. 2017 Mar 30;217:29-33. doi: 10.1016/j.jad.2017.03.059. [Epub ahead of print]

PMID:
28365478
3.

DNA methylation and expression of stress related genes in PBMC of MDD patients with and without serious suicidal ideation.

Roy B, Shelton RC, Dwivedi Y.

J Psychiatr Res. 2017 Jun;89:115-124. doi: 10.1016/j.jpsychires.2017.02.005. Epub 2017 Feb 16.

PMID:
28246044
4.

Poor quality of life and functioning in bipolar disorder.

Sylvia LG, Montana RE, Deckersbach T, Thase ME, Tohen M, Reilly-Harrington N, McInnis MG, Kocsis JH, Bowden C, Calabrese J, Gao K, Ketter T, Shelton RC, McElroy SL, Friedman ES, Rabideau DJ, Nierenberg AA.

Int J Bipolar Disord. 2017 Dec;5(1):10. doi: 10.1186/s40345-017-0078-4. Epub 2017 Mar 27.

5.

Nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol do not affect 6-month mood-stabilizing treatment outcome among 482 patients with bipolar disorder.

Köhler-Forsberg O, Sylvia L, Thase M, Calabrese JR, Deckersbach T, Tohen M, Bowden CL, McInnis M, Kocsis JH, Friedman ES, Ketter TA, McElroy S, Shelton RC, Nierenberg AA.

Depress Anxiety. 2017 Mar;34(3):281-290. doi: 10.1002/da.22601. Epub 2017 Jan 30.

PMID:
28135023
6.

A pilot trial of In vivo NRT sampling to increase medication adherence in community corrections smokers.

Cropsey KL, Hendricks PS, Schiavon S, Sellers A, Froelich M, Shelton RC, Carpenter MJ.

Addict Behav. 2017 Apr;67:92-99. doi: 10.1016/j.addbeh.2016.12.011. Epub 2016 Dec 27.

PMID:
28063325
7.

Dimensions of schizophrenia and their time course of response to a second generation antipsychotic olanzapine-A clinical study.

Birur B, Thirthalli J, Janakiramaiah N, Shelton RC, Gangadhar BN.

Asian J Psychiatr. 2016 Dec;24:17-22. doi: 10.1016/j.ajp.2016.08.007. Epub 2016 Aug 17.

PMID:
27931900
8.

Psilocybin and palliative end-of-life care.

Shelton RC, Hendricks PS.

J Psychopharmacol. 2016 Dec;30(12):1207-1208. No abstract available.

PMID:
27909170
9.

Ziprasidone Augmentation of Escitalopram for Major Depressive Disorder: Cardiac, Endocrine, Metabolic, and Motoric Effects in a Randomized, Double-Blind, Placebo-Controlled Study.

Mischoulon D, Shelton RC, Baer L, Bobo WV, Curren L, Fava M, Papakostas GI.

J Clin Psychiatry. 2017 Apr;78(4):449-455. doi: 10.4088/JCP.15m10426.

PMID:
27835715
10.

Depression, Antidepressants, and Weight Gain in Children.

Shelton RC.

Obesity (Silver Spring). 2016 Dec;24(12):2450. doi: 10.1002/oby.21688. Epub 2016 Nov 2. No abstract available.

PMID:
27804263
11.

Willingness of Mentally Ill Individuals to Sign Up for a Novel Proposal to Prevent Firearm Suicide.

Vars FE, McCullumsmith CB, Shelton RC, Cropsey KL.

Suicide Life Threat Behav. 2016 Oct 5. doi: 10.1111/sltb.12302. [Epub ahead of print]

PMID:
27704597
12.

Impact of acute psychological stress on cardiovascular risk factors in face of insulin resistance.

Jones KT, Shelton RC, Wan J, Li L.

Stress. 2016 Nov;19(6):585-592. Epub 2016 Sep 20.

PMID:
27588343
13.

Identification of MicroRNA-124-3p as a Putative Epigenetic Signature of Major Depressive Disorder.

Roy B, Dunbar M, Shelton RC, Dwivedi Y.

Neuropsychopharmacology. 2017 Mar;42(4):864-875. doi: 10.1038/npp.2016.175. Epub 2016 Aug 31.

PMID:
27577603
14.

Tracking medication changes to assess outcomes in comparative effectiveness research: A bipolar CHOICE study.

Reilly-Harrington NA, Sylvia LG, Rabideau DJ, Gold AK, Deckersbach T, Bowden CL, Bobo WV, Singh V, Calabrese JR, Shelton RC, Friedman ES, Thase ME, Kamali M, Tohen M, McInnis MG, McElroy SL, Ketter TA, Kocsis JH, Kinrys G, Nierenberg AA.

J Affect Disord. 2016 Nov 15;205:159-164. doi: 10.1016/j.jad.2016.07.007. Epub 2016 Jul 5.

PMID:
27449548
15.

Specific Pharmacological Effects of Paroxetine Comprise Psychological but Not Somatic Symptoms of Depression.

Schalet BD, Tang TZ, DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC.

PLoS One. 2016 Jul 20;11(7):e0159647. doi: 10.1371/journal.pone.0159647. eCollection 2016.

16.

Ziprasidone augmentation for anxious depression.

Ionescu DF, Shelton RC, Baer L, Meade KH, Swee MB, Fava M, Papakostas GI.

Int Clin Psychopharmacol. 2016 Nov;31(6):341-6. doi: 10.1097/YIC.0000000000000133.

PMID:
27306192
17.

White blood cell count correlates with mood symptom severity and specific mood symptoms in bipolar disorder.

Köhler O, Sylvia LG, Bowden CL, Calabrese JR, Thase M, Shelton RC, McInnis M, Tohen M, Kocsis JH, Ketter TA, Friedman ES, Deckersbach T, Ostacher MJ, Iosifescu DV, McElroy S, Nierenberg AA.

Aust N Z J Psychiatry. 2017 Apr;51(4):355-365. doi: 10.1177/0004867416644508. Epub 2016 Jul 11.

PMID:
27126391
18.

Notice of Retraction and Replacement. Hollon et al. Effect of cognitive therapy with antidepressant medications vs antidepressants alone on the rate of recovery in major depressive disorder: a randomized clinical trial. JAMA Psychiatry. 2014;71(10):1157-1164.

Hollon SD, DeRubeis RJ, Fawcett J, Amsterdam JD, Shelton RC, Zajecka J, Young PR, Gallop R.

JAMA Psychiatry. 2016 Jun 1;73(6):639-40. doi: 10.1001/jamapsychiatry.2016.0756. No abstract available.

PMID:
27097060
19.

A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression.

Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Van Nueten L.

Am J Psychiatry. 2016 Aug 1;173(8):816-26. doi: 10.1176/appi.ajp.2016.16010037. Epub 2016 Apr 8.

PMID:
27056608
20.

Supplemental Content

Loading ...
Support Center